Presentation TCT 2025 TCT 1515: Vein to Valve: Innovative Percutaneous Debulking in High-Risk Tricuspid Endocarditis Presenter: Omar Al-Abboud October 25, 2025
Presentation TCT 2025 TCT 1514: From Septic to Stable: A Tricuspid Turnaround With Percutaneous Aspiration Presenter: Sampada Kuwar October 25, 2025
Presentation TCT 2025 TCT 1513: Transcatheter Treatment of Evoque TTVR Endocarditis Presenter: Deven Ray Rajagopal October 25, 2025
Presentation TCT 2025 Skills and Tools Useful in Management of Tricuspid Endocarditis and Thrombosis Presenter: Sameh Sayfo October 25, 2025
Presentation TCT 2025 Outcomes of Transcatheter Tricuspid Valve Replacement in Patients with and without Cardiac Implantable Electronic Devices Presenter: Santiago Garcia October 25, 2025
Presentation TCT 2025 Clinical Outcomes of the LuX-Valve Plus Transjugular Tricuspid Valve Replacement System: 6-Month Results of the TRINITY Trial Presenter: Thomas Elie Modine October 25, 2025
Presentation TCT 2025 TCT 1505: Concurrent Mitral and Tricuspid Ring Failures: What to Do? Presenter: Zaid Ali Abdulelah October 25, 2025
Presentation TCT 2025 TCT 1310: Emergent Tricuspid Valve-in-Valve TTVR After Evoque Ventricularization Presenter: George Hanna October 25, 2025
Presentation TCT 2025 TCT 224: Transcatheter Tricuspid Valve Replacement with Evoque after Tricuspid Transcatheter Edge-to-Edge Repair Presenter: Dhiren Ray Rajagopal October 25, 2025
Presentation TCT 2025 TCT 221: Global Insights from the TRICUS Registry: Real-World Outcomes with TricValve Bi-Caval Valve Therapy for Tricuspid Regurgitation Presenter: Philipp Nikolai October 25, 2025
Presentation TCT 2025 TCT 27: Acute Tricuspid Valve Annulus Remodeling After Transcatheter Edge-to-Edge Repair With TriClip Presenter: Valeria Cammalleri October 25, 2025
News Opinion Editor's Corner TCT 2025 What’s Going to Be Hot at TCT 2025 Michael O'Riordan October 09, 2025
News Conference News TCT 2024 Percutaneous Mechanical Aspiration Promising for Right-Heart Infective Endocarditis Caitlin E. Cox November 08, 2024
News Conference News TCT 2024 TRISCEND II: Full Results a Win for TTVR in Severe Tricuspid Regurgitation Michael O'Riordan October 30, 2024
Presentation TCT 2024 Patient-Reported Outcomes are a True Measure of TTVI Value Presenter: John Spertus October 30, 2024
Presentation TCT 2024 CV Event Reduction is the Essential Criterion for Implementing New Device Therapies Presenter: Ori Ben-Yehuda October 30, 2024